P. McCarthy

发表

P. McCarthy, 1994 .

Agricultural chemical exposures and birth defects in the Eastern Cape Province, South Africa A case – control study

M. Mahoney, K. Moysich, P. McCarthy, 2003, Environmental health : a global access science source.

Caring for survivors of the Chernobyl disaster. What the clinician should know.

S. Kripalani, W. Schull, P. McCarthy, 1995, JAMA.

The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute myeloid leukemia in children: an evidence-based review.

R. Arceci, Y. Ravindranath, P. McCarthy, 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

he Role of Cytotoxic Therapy with ematopoietic Stem Cell Transplantation in the herapy of Acute Lymphoblastic Leukemia in hildren: An Evidence-Based Review

R. Larson, P. Gaynon, P. McCarthy, 2005 .

A general method for preparing histologic sections with a water-soluble wax.

P. McCarthy, H. Blank, 1950, The Journal of laboratory and clinical medicine.

Summary of the Second Annual BMT CTN Myeloma Intergroup Workshop on Minimal Residual Disease and Immune Profiling.

A. Krishnan, N. Munshi, N. Puig, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of myelodysplastic syndromes: an evidence-based review.

H. Deeg, J. Bennett, S. Gore, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Excess diagnosis of non-Hodgkin's lymphoma during spring in the USA

H. Risch, H. Swede, Stella Koutros, 2007, Leukemia & lymphoma.

Discontinuation of Systematic Surveillance and Contact Precautions for Vancomycin-Resistant Enterococcus (VRE) and Its Impact on the Incidence of VRE faecium Bacteremia in Patients with Hematologic Malignancies

P. McCarthy, G. Samonis, M. Wetzler, 2016, Infection Control & Hospital Epidemiology.

A non-vacuum freezing-dehydrating technic for histology, autoradiography and microbial cytology.

P. McCarthy, E. Delamater, H. Blank, 1951, Stain technology.

The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute lymphoblastic leukemia in adults: an evidence-based review.

R. Larson, P. Gaynon, P. McCarthy, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Chronic desquamative gingivitis: A reconsideration

G. Shklar, P. McCarthy, F. P. McCarthy, 1960 .

Severity of chronic graft-versus-host disease: association with treatment-related mortality and relapse.

John P Klein, Daniel J Weisdorf, J. Klein, 2002, Blood.

Host-Derived CD70 Suppresses Murine Graft-versus-Host Disease by Limiting Donor T Cell Expansion and Effector Function

J. Ashwell, Jingxin Qiu, P. McCarthy, 2017, The Journal of Immunology.

Acute GVHD prophylaxis with standard-dose, micro-dose or no MTX after fludarabine/melphalan conditioning

P. McCarthy, T. Hahn, M. Ross, 2014, Bone Marrow Transplantation.

Reduced Intensity Transplants for Lymphoma : Reduced Intensity versus Full Transplant 9

B. Sandmaier, J. Dipersio, C. Bollard, 2013 .

Update on the role of lenalidomide in patients with multiple myeloma

V. Suman, S. Holstein, P. McCarthy, 2018, Therapeutic advances in hematology.

VAD-t (Vincristine, Adriamycin, Dexamethasone and Low-Dose Thalidomide) Is an Effective Initial Therapy with High Response Rates for Patients with Treatment Naïve Multiple Myeloma (MM).

Arif Alam, M. Czuczman, A. Chanan-Khan, 2004 .

Multiple functional variants in the IL1RL1 region are pretransplant markers for risk of GVHD and infection deaths.

Lara E Sucheston-Campbell, Abbas A. Rizvi, C. Haiman, 2019, Blood advances.

Common Genetic Variants Are Associated with Accelerated Bone Mineral Density Loss after Hematopoietic Cell Transplantation

N. Nowak, J. Conroy, C. Ambrosone, 2011, PloS one.

Summary of the 2019 BMT CTN Myeloma Intergroup Workshop on Minimal Residual Disease and Immune Profiling.

M. Dhodapkar, N. Puig, M. Samur, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

The 2020 BMT CTN Myeloma Intergroup Workshop on Immune Profiling and Minimal Residual Disease Testing in Multiple Myeloma.

N. Bolli, P. L. Bergsagel, M. Pasquini, 2021, Transplantation and cellular therapy.

A comparison of measured creatinine clearance versus calculated glomerular filtration rate for assessment of renal function before autologous and allogeneic BMT.

P. McCarthy, T. Hahn, M. Battiwalla, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Genome-Wide Association Analyses Identify Variants in IRF4 Associated With Acute Myeloid Leukemia and Myelodysplastic Syndrome Susceptibility

Lara E Sucheston-Campbell, Abbas A. Rizvi, Lara E. Sucheston-Campbell, 2019, bioRxiv.

Detection of extra-medullary relapse of acute lymphoblastic leukemia by radiographic imaging following allogeneic hematopoietic SCT

W. Bshara, P. McCarthy, M. Barcos, 2009, Bone Marrow Transplantation.

Summary of the Third Annual BMT CTN Myeloma Intergroup Workshop on Minimal Residual Disease and Immune Profiling.

N. Munshi, P. Hari, M. Pasquini, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Allogeneic bone marrow transplantation for refractory and recurrent low-grade lymphoma: the case for aggressive management.

B. Andersson, K. van Besien, P. McCarthy, 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Allogeneic bone marrow transplantation for poor-prognosis lymphoma: response, toxicity and survival depend on disease histology.

H. Kantarjian, A. Deisseroth, B. Andersson, 1996, The American journal of medicine.

Simplified validated prognostic model for progression-free survival after autologous transplantation for hodgkin lymphoma.

S. Montoto, P. Hari, P. McCarthy, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Comparing thermal stress reduction strategies that influence MDSC accumulation in tumor bearing mice.

B. Hylander, E. Repasky, P. McCarthy, 2021, Cellular immunology.

Impact of imatinib therapy on the use of allogeneic haematopoietic progenitor cell transplantation for the treatment of chronic myeloid leukaemia

M. Horowitz, J. Goldman, Stephanie J. Lee, 2007, British journal of haematology.

Future Directions in Maintenance Therapy in Multiple Myeloma

V. Suman, S. Holstein, P. McCarthy, 2021, Journal of clinical medicine.

Maintenance Treatment and Survival in Patients With Myeloma: A Systematic Review and Network Meta-analysis

G. Morgan, P. Sonneveld, M. Boccadoro, 2018, JAMA oncology.

The emerging role of consolidation and maintenance therapy for transplant-eligible multiple myeloma patients

H. Einsele, P. McCarthy, M. Attal, 2014, Expert review of hematology.

Strategies for induction, autologous hematopoietic stem cell transplantation, consolidation, and maintenance for transplantation-eligible multiple myeloma patients.

P. McCarthy, T. Hahn, 2013, Hematology. American Society of Hematology. Education Program.

"Sowing dragon's teeth?" Myeloma and AML.

K. Owzar, P. McCarthy, K. Anderson, 2011, Blood.

Geriatric assessment predicts survival and toxicities in elderly myeloma patients: an International Myeloma Working Group report.

K. Anderson, M. Dimopoulos, H. Einsele, 2015, Blood.

Rituximab in combination with fludarabine chemotherapy in low-grade or follicular lymphoma.

M. Czuczman, L. Blumenson, A. Chanan-Khan, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A comparison of HLA-identical sibling allogeneic versus autologous transplantation for diffuse large B cell lymphoma: a report from the CIBMTR.

J. Vose, J. Winter, P. Hari, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Thyroid cancer incidence trends in Belarus: examining the impact of Chernobyl.

M. Mahoney, K. Moysich, P. McCarthy, 2004, International journal of epidemiology.

Design and analysis of epidemiological studies of excess cancer among children exposed to chernobyl radionuclides

Leif E. Peterson, J. L. Smith, P. McCarthy, 1997, Stem cells.

Pregnancy after hematopoietic cell transplantation: a report from the late effects working committee of the Center for International Blood and Marrow Transplant Research (CIBMTR).

M. Sorror, J. Wingard, M. Gilleece, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Cytoreduction with gemtuzumab ozogamicin and cytarabine prior to allogeneic stem cell transplant for relapsed/refractory acute myeloid leukemia

G. Wilding, P. Wallace, P. McCarthy, 2012, Leukemia & lymphoma.

High prevalence of early-onset osteopenia/osteoporosis after allogeneic stem cell transplantation and improvement after bisphosphonate therapy

P. McCarthy, T. Hahn, M. Battiwalla, 2008, Bone Marrow Transplantation.

The Chernobyl childhood leukemia study: background & lessons learned

M. Mahoney, K. Moysich, P. McCarthy, 2004, Environmental health : a global access science source.

Pilot Study of Patient and Caregiver Out-of-Pocket Costs of Allogeneic Hematopoietic Cell Transplantation

Stephanie J. Lee, P. McCarthy, T. Hahn, 2012, Bone Marrow Transplantation.

Inhibition of interleukin-1 by an interleukin-1 receptor antagonist prevents graft-versus-host disease.

R. Thompson, P. McCarthy, S. Neben, 1991, Blood.

Down-regulation of cytokine action.

P. McCarthy, 1994, Bailliere's clinical haematology.

Abandonment of high-dose chemotherapy/hematopoietic cell transplants for breast cancer following negative trial results.

P. McCarthy, H. Lazarus, D. Howard, 2011, Health services research.

A deletion polymorphism in glutathione-S-transferase mu (GSTM1) and/or theta (GSTT1) is associated with an increased risk of toxicity after autologous blood and marrow transplantation.

C. Ambrosone, L. Sucheston, P. McCarthy, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Updated analysis of CALGB/ECOG/BMT CTN 100104: Lenalidomide (Len) vs. placebo (PBO) maintenance therapy after single autologous stem cell transplant (ASCT) for multiple myeloma (MM).

K. Owzar, C. Hofmeister, R. Vij, 2015 .

Lenalidomide (LEN) maintenance (MNTC) after high-dose melphalan and autologous stem cell transplant (ASCT) in multiple myeloma (MM): A meta-analysis (MA) of overall survival (OS).

P. Richardson, P. Moreau, S. Holstein, 2016 .

Analysis of Second Primary Malignancies (SPMs) in CALGB (Alliance)/ECOG/BMT CTN 100104

K. Owzar, C. Hofmeister, R. Vij, 2015 .

Second primary malignancies with lenalidomide therapy for newly diagnosed myeloma: a meta-analysis of individual patient data.

B. Barlogie, M. Dimopoulos, P. Sonneveld, 2014, The Lancet. Oncology.

Reversible cardiotoxicity with tyrosine kinase inhibitors.

M. Ahluwalia, P. McCarthy, M. Wetzler, 2010, Clinical advances in hematology & oncology : H&O.

Multiple myeloma: future directions in autologous transplantation and novel agents.

P. Hari, P. McCarthy, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Elevating body temperature enhances hematopoiesis and neutrophil recovery after total body irradiation in an IL-1-, IL-17-, and G-CSF-dependent manner.

E. Repasky, P. McCarthy, T. Mace, 2012, Blood.

A TLR5 Agonist Enhances CD8+ T Cell-Mediated Graft-versus-Tumor Effect without Exacerbating Graft-versus-Host Disease

A. Gudkov, Jingxin Qiu, L. Burdelya, 2012, The Journal of Immunology.

Medical management of pneumatosis intestinalis in patients undergoing allogeneic blood and marrow transplantation

M. Ahluwalia, J. Thomas, P. McCarthy, 2009, Bone Marrow Transplantation.

Anti-Platelet-Derived Growth Factor Receptor Alpha Chain Antibodies Predict for Response to Nilotinib in Steroid-Refractory or -Dependent Chronic Graft-Versus-Host Disease.

D. Miklos, B. Storer, Jingxin Qiu, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Fatal diffuse alveolar hemorrhage associated with sirolimus after allogeneic hematopoietic cell transplantation

P. McCarthy, T. Hahn, M. Battiwalla, 2010, Bone Marrow Transplantation.

Risk-associations between HLA-DPB1 T cell epitope matching and outcome of unrelated hematopoietic cell transplantation are independent from HLA-DPA1

D. Miklos, Stephanie J. Lee, M. Heemskerk, 2014, Bone Marrow Transplantation.

The Role of Cytotoxic Therapy with Hematopoietic Stem Cell Transplantation in the Therapy of Multiple Myeloma : An Evidenced-Based Review

R. Kyle, J. Wingard, P. McCarthy, 2022 .

he Role of Cytotoxic Therapy with Hematopoietic tem Cell Transplantation in the Therapy of Acute yeloid Leukemia in Children : An Evidence-Based eview

R. Arceci, Y. Ravindranath, P. McCarthy, 2007 .

It takes a village ( of therapies ) to achieve optimal long-term outcomes for multiple myeloma

B. Sandmaier, J. Dipersio, C. Bollard, 2022 .

Invasive filamentous fungal infections in allogeneic hematopoietic stem cell transplant recipients after recovery from neutropenia: Clinical, radiologic, and pathologic characteristics

M. Czuczman, P. McCarthy, T. Walsh, 2005, Mycopathologia.

T Cell–Derived CD70 Delivers an Immune Checkpoint Function in Inflammatory T Cell Responses

Kelvin P Lee, Jingxin Qiu, P. McCarthy, 2017, The Journal of Immunology.

Shared graft-versus-leukemia minor histocompatibility antigens in DISCOVeRY-BMT

Lara E Sucheston-Campbell, Dante S. Bortone, Lara E. Sucheston-Campbell, 2022, bioRxiv.

Dextramer reagents are effective tools for quantifying CMV antigen‐specific T cells from peripheral blood samples

P. Wallace, P. McCarthy, J. Tario, 2014, Cytometry. Part B, Clinical cytometry.

Deciphering spatial genomic heterogeneity at a single cell resolution in multiple myeloma

Q. Hu, Song Liu, N. Munshi, 2021, Nature communications.

Comparison of graft-versus-host-disease and survival after HLA-identical sibling bone marrow transplantation in ethnic populations.

J. Fay, M. Horowitz, R. Gale, 2005, Blood.

COMPARISON OF GRAFT-VS-HOST-DISEASE AND SURVIVAL AFTER HLA- IDENTICAL SIBLING BONE MARROW TRANSPLANTATION IN DIFFERENT ETHNIC POPULATIONS Running Head: Graft-vs-host disease in ethnic populations For Submission to BLOOD, Clinical Observations

J. Fay, M. Horowitz, R. Gale, 2004 .

A clinical phase I/II study of recombinant human interleukin-1 receptor in glucocorticoid-resistant graft-versus-host disease.

P. McCarthy, C. Anasetti, D. Przepiorka, 1996, Transplantation.

Associations of Minor Histocompatibility Antigens with Clinical Outcomes Following Allogeneic Hematopoietic Cell Transplantation

Lara E Sucheston-Campbell, Lara E. Sucheston-Campbell, C. Haiman, 2022, bioRxiv.

Prospective Validation of the Predictive Power of the Hematopoietic Cell Transplantation Comorbidity Index: A CIBMTR ® Study

M. Sorror, M. Pasquini, Xiaochun Zhu, 2015 .

Commentary on “Is posttransplant lenalidomide the standard-of-care after an autotransplant for plasma cell myeloma” by Giovanni Barosi and Robert Peter Gale

V. Suman, S. Holstein, P. McCarthy, 2019, Leukemia.

Outcome of transplantation for myelofibrosis.

N. Kröger, M. Horowitz, R. Gale, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

One-antigen mismatched related versus HLA-matched unrelated donor hematopoietic stem cell transplantation in adults with acute leukemia: Center for International Blood and Marrow Transplant Research results in the era of molecular HLA typing.

J. Sierra, Stephanie J. Lee, O. Ringdén, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Endpoints for Clinical Trials Testing Treatment of Acute Graft- versus-host Disease: A Consensus Document

R. Soiffer, P. McCarthy, M. MacMillan, 2010 .

Endpoints for clinical trials testing treatment of acute graft-versus-host disease: a joint statement.

E. Shpall, R. Soiffer, P. McCarthy, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Umbilical cord blood transplantation in adults: results of the prospective Cord Blood Transplantation (COBLT).

K. Cornetta, J. Wagner, P. McCarthy, 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Immune profiling in Diffuse Large B-Cell Lymphoma and Mantle Cell Lymphoma Patients treated with Autologous Hematopoietic Cell Transplant

P. Wallace, F. Hernandez-Ilizaliturri, E. Repasky, 2019, Bone Marrow Transplantation.

The role of cytotoxic therapy with hematopoietic stem cell transplantation in the treatment of diffuse large B cell lymphoma: update of the 2001 evidence-based review.

J. Vose, M. Czuczman, R. Fisher, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Linezolid-Resistant Enterococcus faecalis Isolated from a Cord Blood Transplant Recipient

S. Pillai, P. McCarthy, M. Wetzler, 2004, Journal of Clinical Microbiology.

Effect of body mass in children with hematologic malignancies undergoing allogeneic bone marrow transplantation.

M. Pasquini, Xiaochun Zhu, P. McCarthy, 2014, Blood.

undergoing allogeneic bone marrow transplantation Effect of body mass in children with hematologic malignancies

M. Pasquini, Xiaochun Zhu, P. McCarthy, 2014 .

Adoptive immunotherapy by allogeneic stem cell transplantation for metastatic renal cell carcinoma: a CALGB intergroup phase II study.

E. Small, B. Rini, W. Stadler, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Histopathology of oral lesions of discoid lupus erythematosus. A review of 25 cases.

G. Shklar, P. McCarthy, 1978, Archives of dermatology.

Effect of rituximab on peripheral blood stem cell mobilization and engraftment kinetics in non-Hodgkin's lymphoma patients

M. Czuczman, A. Chanan-Khan, P. McCarthy, 2003, Bone Marrow Transplantation.

syndrome and acute myeloid leukemia Allogeneic transplantation for therapy-related myelodysplastic

J. Sierra, J. Dipersio, S. Tarima, 2011 .

Allogeneic transplantation for therapy-related myelodysplastic syndrome and acute myeloid leukemia.

J. Sierra, J. Dipersio, S. Tarima, 2010, Blood.

CD319 (SLAMF7) an alternative marker for detecting plasma cells in the presence of daratumumab or elotuzumab

P. Wallace, P. McCarthy, J. Tario, 2020, Cytometry. Part B, Clinical cytometry.

BMT CTN Myeloma Intergroup Workshop on Minimal Residual Disease and Immune Profiling: Summary and Recommendations from the Organizing Committee.

J. Lohr, N. Munshi, P. Wallace, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Myeloablative allogeneic hematopoietic stem cell transplantation in patients who experience relapse after autologous stem cell transplantation for lymphoma: a report of the International Bone Marrow Transplant Registry.

J. Vose, M. Horowitz, R. Gale, 2004, Blood.

Rituximab in combination with CHOP or fludarabine in low-grade lymphoma.

M. Czuczman, P. McCarthy, D. Klippenstein, 2002, Seminars in oncology.

Early versus Late Pre-emptive Allogeneic Hematopoietic Cell Transplantation (p-alloHCT) for Relapsed or Refractory Acute Myeloid Leukemia (AML)

G. Deeb, S. Sait, P. McCarthy, 2015 .

Role of cytotoxic therapy with hematopoietic stem cell transplantation in the treatment of pediatric acute lymphoblastic leukemia: update of the 2005 evidence-based review.

P. Gaynon, P. McCarthy, M. Pulsipher, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

The role of cytotoxic therapy with hematopoietic stem cell transplantation in the treatment of adult acute lymphoblastic leukemia: update of the 2006 evidence-based review.

R. Larson, P. McCarthy, T. Ratko, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Phase III Intergroup Study of Lenalidomide Versus Placebo Maintenance Therapy Following Single Autologous Hematopoietic Stem Cell Transplantation (AHSCT) for Multiple Myeloma: CALGB 100104

K. Owzar, C. Hofmeister, R. Vij, 2010 .

Impact of prior imatinib mesylate on the outcome of hematopoietic cell transplantation for chronic myeloid leukemia.

A. Zander, J. Szer, M. Horowitz, 2008, Blood.

PROGNOSTIC FACTORS FOR OUTCOMES IN ALLOGENEIC TRANSPLANTATION FOR ADVANCED PHASES OF CHRONIC MYELOID LEUKEMIA IN THE IMATINIB ERA: A CIBMTR ANALYSIS

J. Cortes, J. Szer, M. Horowitz, 2011, Bone Marrow Transplantation.

The role of cytotoxic therapy with hematopoietic stem cell transplantation in the treatment of follicular lymphoma: an evidence-based review.

L. Gordon, J. Leonard, P. Mclaughlin, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Risk factors for acute GVHD and survival after hematopoietic cell transplantation.

M. Horowitz, R. Gale, Stephanie J. Lee, 2012, Blood.

Reply to Hattori et al: Thalidomide and pulmonary hypertension. A causal or casual relationship?

P. McCarthy, T. Younis, 2005 .

Next-Generation Drugs Targeting the Cereblon Ubiquitin Ligase.

S. Holstein, P. McCarthy, J. Hillengass, 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II trial of parathyroid hormone after double umbilical cord blood transplantation.

E. Shpall, J. Wingard, K. Ballen, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Phase II Trial of Parathyroid Hormone following Double Umbilical Cord Blood Transplantation

E. Shpall, J. Wingard, K. Ballen, 2012 .

Population-Based Analysis of Hematologic Malignancy Referrals to a Comprehensive Cancer Center, Referrals for Blood and Marrow Transplantation, and Participation in Clinical Trial, Survey, and Biospecimen Research by Race.

K. Moysich, P. McCarthy, T. Hahn, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Long-term outcomes of adults with acute lymphoblastic leukemia after autologous or unrelated donor bone marrow transplantation: a comparative analysis by the National Marrow Donor Program and Center for International Blood and Marrow Transplant Research

M. Horowitz, M. Bishop, Carole B. Miller, 2008, Bone Marrow Transplantation.

Role of stem cell transplant and maintenance therapy in plasma cell disorders.

S. Holstein, P. McCarthy, 2016, Hematology. American Society of Hematology. Education Program.

Multiple myeloma.

S. Holstein, P. McCarthy, Hong Liu, 2014, Hematology/oncology clinics of North America.

The graft-versus-leukemia effect using matched unrelated donors is not superior to HLA-identical siblings for hematopoietic stem cell transplantation.

A. Barrett, M. Horowitz, J. Wingard, 2009, Blood.

β2-adrenergic receptor activation on donor cells ameliorates acute GvHD.

E. Repasky, Jingxin Qiu, P. McCarthy, 2020, JCI insight.

A New Measure Of Symptom Burden In Chronic Graft-Versus-Host Disease

C. Cleeland, T. Mendoza, P. McCarthy, 2010 .

Chronic myeloid leukemia after treatment of lymphoid malignancies: response to imatinib mesylate and favorable outcomes in three patients.

S. Sait, P. McCarthy, M. Baer, 2006, Leukemia research.

Remestemcel-L for acute graft-versus-host disease therapy

P. McCarthy, George L. Chen, P. Paplham, 2014, Expert opinion on biological therapy.

hematopoietic stem cell transplantation Impact of posttransplantation G-CSF on outcomes of allogeneic

R. Gale, H. Khoury, P. McCarthy, 2011 .

Impact of posttransplantation G-CSF on outcomes of allogeneic hematopoietic stem cell transplantation.

M. Horowitz, R. Gale, P. Tiberghien, 2006, Blood.

Acute renal failure requiring dialysis after allogeneic blood and marrow transplantation identifies very poor prognosis patients

M. Czuczman, A. Chanan-Khan, Austin Miller, 2003, Bone Marrow Transplantation.

B mbilical Cord Blood Transplantation in Adults : esults of the Prospective Cord Blood ransplantation ( COBLT )

K. Cornetta, J. Wagner, P. McCarthy, 2005 .

Diseasewithout Exacerbating Graft-versus-Host Cell-Mediated Graft-versus-Tumor Effect T + A TLR5 Agonist Enhances CD8

A. Gudkov, Jingxin Qiu, L. Burdelya, 2012 .

Progressive chronic lymphocytic leukemia after allogeneic hematopoietic cell transplantation.

A. Desai, P. McCarthy, M. Ross, 2012, Journal of the National Comprehensive Cancer Network : JNCCN.

Prospective cohort study comparing intravenous busulfan to total body irradiation in hematopoietic cell transplantation.

J. Dipersio, F. Appelbaum, M. Pasquini, 2013, Blood.

Determination of Minimal Residual Disease in Multiple Myeloma: Does It Matter?

S. Holstein, P. McCarthy, J. Hillengass, 2019, Current Hematologic Malignancy Reports.

Should Overall Survival Remain an Endpoint for Multiple Myeloma Trials?

V. Suman, S. Holstein, P. McCarthy, 2019, Current Hematologic Malignancy Reports.

Multiparameter flow cytometry for the diagnosis and monitoring of small GPI‐deficient cellular populations

M. Ahluwalia, P. Wallace, P. Starostik, 2010, Cytometry. Part B, Clinical cytometry.

Trends in use of and survival after autologous hematopoietic cell transplantation in North America, 1995-2005: significant improvement in survival for lymphoma and myeloma during a period of increasing recipient age.

Stephanie J. Lee, P. McCarthy, H. Lazarus, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Treatment with plerixafor in non-Hodgkin's lymphoma and multiple myeloma patients to increase the number of peripheral blood stem cells when given a mobilizing regimen of G-CSF: implications for the heavily pretreated patient.

M. Territo, P. McCarthy, K. Badel, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Blockade of Host β2-Adrenergic Receptor Enhances Graft-versus-Tumor Effect through Modulating APCs

E. Repasky, Jingxin Qiu, P. McCarthy, 2018, The Journal of Immunology.

transplantation Risk factors for acute GVHD and survival after hematopoietic cell

M. Horowitz, R. Gale, Stephanie J. Lee, 2012 .

Comparative analysis of BU and CY versus CY and TBI in full intensity unrelated marrow donor transplantation for AML, CML and myelodysplasia

S. Tarima, O. Ringdén, P. McCarthy, 2011, Bone Marrow Transplantation.

Outcome of patients with IgD and IgM multiple myeloma undergoing autologous hematopoietic stem cell transplantation: a retrospective CIBMTR study.

H. Atkins, P. Hari, A. Dispenzieri, 2010, Clinical lymphoma, myeloma & leukemia.

BPX-501 T cells interfere with minimal residual disease evaluation of B-cell acute lymphoblastic leukemia

P. Wallace, M. Borowitz, P. McCarthy, 2018, Bone Marrow Transplantation.

Weekly prophylactic urokinase instillation in tunneled central venous access devices.

J. Kaufman, P. McCarthy, C. Ray, 1999, Journal of vascular and interventional radiology : JVIR.

Use of nonvolume-reduced (unmanipulated after thawing) umbilical cord blood stem cells for allogeneic transplantation results in safe engraftment

P. McCarthy, B. Bambach, T. Hahn, 2003, Bone Marrow Transplantation.

Significant improvement in survival after allogeneic hematopoietic cell transplantation during a period of significantly increased use, older recipient age, and use of unrelated donors.

Stephanie J. Lee, P. McCarthy, H. Lazarus, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Human leukocyte antigen (HLA) DR15 is associated with reduced incidence of acute GVHD in HLA-matched allogeneic transplantation but does not impact chronic GVHD incidence.

A. Barrett, P. McCarthy, T. Hahn, 2006, Blood.

Risk factors for acute graft-versus-host disease after human leukocyte antigen-identical sibling transplants for adults with leukemia.

R. Gale, P. Tiberghien, O. Ringdén, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A phase I/II study of ixazomib, pomalidomide, and dexamethasone for lenalidomide and proteasome inhibitor refractory multiple myeloma (Alliance A061202)

J. Laubach, P. Richardson, S. Tuchman, 2021, American journal of hematology.

Continued role for ASCT in multiple myeloma.

S. Holstein, P. McCarthy, 2015, The Lancet. Oncology.

Impact of conditioning regimen on outcomes for patients with lymphoma undergoing high-dose therapy with autologous hematopoietic cell transplantation.

A. Lane, M. Aljurf, M. Pasquini, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Methodology for updating published evidence-based reviews evaluating the role of blood and marrow transplantation in the treatment of selected diseases: a policy statement by the American Society for Blood and Marrow Transplantation.

J. Wingard, Y. Nieto, P. McCarthy, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Intensive conditioning regimen of etoposide (VP-16), cyclophosphamide and carmustine (VCB) followed by autologous hematopoietic stem cell transplantation for relapsed and refractory Hodgkin's lymphoma

M. Czuczman, F. Hernandez-Ilizaliturri, P. McCarthy, 2008, Bone Marrow Transplantation.

The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute lymphoblastic leukemia in children: an evidence-based review.

R. Larson, P. Gaynon, P. McCarthy, 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Comparable outcomes in nonsecretory and secretory multiple myeloma after autologous stem cell transplantation.

P. Hari, R. Kyle, Shaji K. Kumar, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

transplantation superior to HLA-identical siblings for hematopoietic stem cell The graft-versus-leukemia effect using matched unrelated donors is not

J. Wingard, P. McCarthy, S. Spellman, 2011 .

Long-term use of oral beclomethasone dipropionate for the treatment of gastrointestinal graft-versus-host disease.

P. McCarthy, B. Bambach, R. Iyer, 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Tacrolimus/sirolimus vs tacrolimus/methotrexate as GVHD prophylaxis after matched, related donor allogeneic HCT.

S. Grupp, D. Porter, M. Pasquini, 2014, Blood.

Comparison of twin and autologous transplants for multiple myeloma.

R. Fonseca, P. Hari, R. Kyle, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Granzyme B–Mediated Activation-Induced Death of CD4+ T Cells Inhibits Murine Acute Graft-versus-Host Disease

Jingxin Qiu, P. McCarthy, T. Hahn, 2015, The Journal of Immunology.

Late infectious complications after cord blood stem cell transplantation

P. McCarthy, T. Hahn, M. Wetzler, 2009, European Journal of Clinical Microbiology & Infectious Diseases.

Long-Term Survival With Allogeneic Stem Cell Transplant and Donor Lymphocyte Infusion Following Salvage Therapy with Anti-CD52 Monoclonal Antibody (Campath) in a Patient with α/β Hepatosplenic T-Cell Non-Hodgkin's Lymphoma

M. Czuczman, A. Chanan-Khan, J. Gibbs, 2004 .

Long-term survival with allogeneic stem cell transplant and donor lymphocyte infusion following salvage therapy with anti-CD52 monoclonal antibody (Campath) in a patient with alpha/beta hepatosplenic T-cell non-Hodgkin's lymphoma.

M. Czuczman, A. Chanan-Khan, J. Gibbs, 2004, Leukemia & lymphoma.

Elotuzumab in Combination with Lenalidomide and Dexamethasone for Treatment-resistant Immunoglobulin Light Chain Amyloidosis With Multiple Myeloma.

P. McCarthy, J. Hillengass, S. M. Iqbal, 2019, Clinical lymphoma, myeloma & leukemia.

Minimal Residual Disease (MRD) Assessment before and after Autologous Hematopoietic Cell Transplantation (AutoHCT) and Maintenance for Multiple Myeloma (MM): Results of the Prognostic Immunophenotyping for Myeloma Response (PRIMeR) Study

N. Geller, A. Krishnan, P. Hari, 2019, Biology of Blood and Marrow Transplantation.

Lenalidomide Maintenance After Autologous Stem-Cell Transplantation in Newly Diagnosed Multiple Myeloma: A Meta-Analysis.

Sin-Ho Jung, A. Palumbo, P. Richardson, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Complications of acute leukemia. Case two: epidural chloroma of the lower spinal canal.

P. McCarthy, G. Proulx, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Tacrolimus/Sirolimus Vs. Tacrolimus/Methotrexate for Graft-Vs.-Host Disease Prophylaxis After HLA-Matched, Related Donor Hematopoietic Stem Cell Transplantation: Results of Blood and Marrow Transplant Clinical Trials Network Trial 0402

S. Grupp, D. Porter, M. Pasquini, 2012 .

EFFECTS OF SPLEEN STATUS ON EARLY OUTCOMES AFTER HEMATOPOIETIC CELL TRANSPLANTATION

M. Pasquini, K. Ballen, U. Popat, 2012, Bone Marrow Transplantation.

irradiation in hematopoietic cell transplantation Prospective cohort study comparing intravenous busulfan to total body

J. Dipersio, F. Appelbaum, M. Pasquini, 2013 .

Impact of conditioning regimen on outcomes for patients with lymphoma undergoing high-dose therapy with autologous hematopoietic cell transplantation.

A. Lane, M. Aljurf, M. Pasquini, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

β2-adrenergic receptor signaling regulates metabolic pathways critical to myeloid-derived suppressor cell function within the TME

E. Repasky, S. Abrams, P. McCarthy, 2021, Cell reports.

PHYSICIAN PERCEPTIONS AND PRACTICE PATTERNS REGARDING FERTILITY PRESERVATION IN HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS

M. Sorror, J. Wingard, J. Pidala, 2013, Bone Marrow Transplantation.

R. Gale, M. Bishop, O. Ringdén, 2011, Bone Marrow Transplantation.

Prognostic impact of pre-transplant chromosomal aberrations in peripheral blood of patients undergoing unrelated donor hematopoietic cell transplant for acute myeloid leukemia

Lara E Sucheston-Campbell, Abbas A. Rizvi, S. Chanock, 2021, Scientific Reports.

Lenalidomide after stem-cell transplantation for multiple myeloma.

K. Owzar, C. Hofmeister, R. Vij, 2012, The New England journal of medicine.

Oral lesions of mucous membrane pemphigoid. A study of 85 cases.

G. Shklar, P. McCarthy, 1971, Archives of otolaryngology.

Efficacy of High-Efficiency Particulate Air Filtration in Preventing Aspergillosis in Immunocompromised Patients With Hematologic Malignancies

Theresa Hahn, K. Cummings, P. McCarthy, 2002, Infection Control & Hospital Epidemiology.

Toxic Tacrolimus Levels After Application of Topical Tacrolimus and Use of Occlusive Dressings in Two Bone Marrow Transplant Recipients with Cutaneous Graft‐versus‐Host Disease

P. McCarthy, K. West, K. A. Olson, 2014, Pharmacotherapy.

The oral manifestations of systemic disease

G. Shklar, P. McCarthy, 1976 .

The Microbiome and Hematopoietic Cell Transplantation: Past, Present, and Future.

W. Wood, P. Chiusolo, R. Storb, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Diseases of the Oral Mucosa

G. Shklar, P. McCarthy, 1980 .

The Sequence of Cyclophosphamide and Myeloablative Total Body Irradiation in Hematopoietic Cell Transplantation for Patients with Acute Leukemia.

F. Baron, M. Aljurf, M. Pasquini, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Cryotherapy of basal-cell carcinoma by a simple method of standardized freeze-thaw cycles.

D. McLean, P. McCarthy, H. Baden, 1978, The Journal of dermatologic surgery and oncology.

Blood and Marrow Transplant Handbook

P. McCarthy, Mei-Chu Lin, 2016 .

Ganciclovir inhibits lymphocyte proliferation by impairing DNA synthesis.

P. Wallace, P. McCarthy, T. Hahn, 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

A comparison of cyclophosphamide and total body irradiation with etoposide and total body irradiation as conditioning regimens for patients undergoing sibling allografting for acute lymphoblastic leukemia in first or second complete remission.

Mei-Jie Zhang, David D. Smith, David D Smith, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Human leukocyte antigen DR4 is associated with inferior progression-free survival following allogeneic hematopoietic stem cell transplantation for lymphoid malignancies

P. McCarthy, T. Hahn, C. Aggarwal, 2008, Leukemia & lymphoma.

Cytologic smears in diagnosis of herpes simplex, herpes zoster, and varicella.

F. Urbach, P. McCarthy, H. Blank, 1951, Journal of the American Medical Association.

Diffuse angiomatosis of the tongue.

G. Shklar, P. McCarthy, J. Giunta, 1971, Archives of otolaryngology.

Validation of genetic associations with acute GVHD and nonrelapse mortality in DISCOVeRY-BMT.

Lara E Sucheston-Campbell, Abbas A. Rizvi, Lara E. Sucheston-Campbell, 2019, Blood advances.

Francis P. McCarthy, pioneer in oral medicine.

G. Shklar, P. McCarthy, 2008, Journal of the history of dentistry.

A decision analysis of allogeneic bone marrow transplantation for the myelodysplastic syndromes: delayed transplantation for low-risk myelodysplasia is associated with improved outcome.

John P Klein, Daniel J Weisdorf, Peter Greenberg, 2004, Blood.

Association of squamous cell carcinoma of the oral cavity in allogeneic hematopoietic stem cell transplant recipients

P. McCarthy, T. Hahn, M. Battiwalla, 2007, Bone Marrow Transplantation.

Sarcoidosis-associated MHC Ags and the development of cutaneous and nodal granulomas following allogeneic hematopoietic cell transplant

C. Morrison, P. McCarthy, T. Hahn, 2011, Bone Marrow Transplantation.

Effect of up-front daclizumab when combined with steroids for the treatment of acute graft-versus-host disease: results of a randomized trial.

D. Zahrieh, R. Soiffer, Stephanie J. Lee, 2004, Blood.

International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma.

H. Goldschmidt, M. Dimopoulos, A. Palumbo, 2016, The Lancet. Oncology.

Long-term follow-up of CALGB (Alliance) 100001: Autologous followed by non-myeloablative allogeneic transplant for multiple myeloma.

B. Cheson, K. Owzar, R. Vij, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

SECOND TRANSPLANTS FOR MULTIPLE MYELOMA RELAPSING AFTER A PRIOR AUTOTRANSPLANT – REDUCED INTENSITY ALLOGENEIC VERSUS AUTOLOGOUS TRANSPLANTATION

A. Krishnan, S. Lonial, P. Hari, 2013, Bone Marrow Transplantation.

Race and outcomes of autologous hematopoietic cell transplantation for multiple myeloma.

P. Hari, R. Kyle, D. Reece, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Genetic association with B-cell acute lymphoblastic leukemia in allogeneic transplant patients differs by age and sex.

Lara E Sucheston-Campbell, Abbas A. Rizvi, Lara E. Sucheston-Campbell, 2017, Blood advances.

The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute myelogenous leukemia in adults: an evidence-based review.

F. Appelbaum, M. Tallman, R. Stone, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Replication and validation of genetic polymorphisms associated with survival after allogeneic blood or marrow transplant.

Lara E Sucheston-Campbell, Abbas A. Rizvi, Lara E. Sucheston-Campbell, 2017, Blood.

Immunomodulatory Drugs in Multiple Myeloma: Mechanisms of Action and Clinical Experience

S. Holstein, P. McCarthy, 2017, Drugs.

Deciphering spatial genomic heterogeneity at a single cell resolution in multiple myeloma

Q. Hu, P. Wallace, M. Samur, 2022, Nature Communications.

Pre-HCT mosaicism increases relapse risk and lowers survival in acute lymphoblastic leukemia patients post-unrelated HCT.

Lara E Sucheston-Campbell, S. Chanock, C. Haiman, 2021, Blood advances.

Survival of human macrophages infected with Mycobacterium avium intracellulare correlates with increased production of tumor necrosis factor-alpha and IL-6.

P. McCarthy, H. Gan, H. Remold, 1991, Journal of immunology.

Updated analysis of CALGB 100104 (Alliance): a randomised phase III study evaluating lenalidomide vs placebo maintenance after single autologous stem cell transplant for multiple myeloma

Scott E. Smith, Sin-Ho Jung, K. Owzar, 2017, The Lancet. Haematology.

The role of microtubules in the response of macrophages to MIF.

P. McCarthy, J. Shaw, H. Remold, 1979, Cellular immunology.

Autologous versus allogeneic unrelated donor transplantation for acute lymphoblastic leukemia: comparative toxicity and outcomes.

J. Klein, J. Sierra, M. Horowitz, 2002, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Housing Temperature–Induced Stress Is Suppressing Murine Graft-versus-Host Disease through β2-Adrenergic Receptor Signaling

J. Farrar, E. Repasky, Jingxin Qiu, 2015, The Journal of Immunology.

Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune effector cell-related adverse events

Matthew J. Frigault, D. Teachey, S. Grupp, 2020, Journal for ImmunoTherapy of Cancer.

Thiotepa-associated cardiomyopathy during blood or marrow transplantation: association with the female sex and cardiac risk factors.

M. Czuczman, P. McCarthy, B. Bambach, 1999, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

High‐efficiency electrotransfection of human primary hematopoietic stem sells

P. McCarthy, S. Hui, L. Li, 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients.

Andrea Bacigalupo, Philip McCarthy, E. Shpall, 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Increasing incidence of chronic graft-versus-host disease in allogeneic transplantation: a report from the Center for International Blood and Marrow Transplant Research.

Tao Wang, Thomas Spitzer, Daniel J Weisdorf, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

The evolving role of maintenance therapy following autologous stem cell transplantation in multiple myeloma

S. Holstein, A. Merz, M. Merz, 2019, Expert review of anticancer therapy.

Influence of various factors on individual radiation exposure from the chernobyl disaster

M. Mahoney, K. Moysich, P. McCarthy, 2002, Environmental health : a global access science source.

The oral lesions of lichen planus

G. Shklar, P. McCarthy, 1961 .

J. Armitage, J. Fay, J. Klein, 1999, JAMA.

HLA-identical sibling allogeneic transplants versus chemotherapy in acute myelogenous leukemia with t(8;21) in first complete remission: collaborative study between the German AML Intergroup and CIBMTR.

R. Schlenk, H. Döhner, A. Ganser, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Effect of postremission chemotherapy before human leukocyte antigen-identical sibling transplantation for acute myelogenous leukemia in first complete remission.

M. Horowitz, M. Tallman, R. Gale, 2000, Blood.

The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of diffuse large cell B-cell non-Hodgkin's lymphoma: an evidence-based review.

J. Vose, M. Czuczman, R. Fisher, 2001, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Classifying cytogenetics in patients with acute myelogenous leukemia in complete remission undergoing allogeneic transplantation: a Center for International Blood and Marrow Transplant Research study.

Alan M. Miller, P. D. Dal Cin, J. Sierra, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

High-dose chemotherapy with autologous hematopoietic stem-cell support for breast cancer in North America.

J. Armitage, J. Fay, J. Klein, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Oral manifestations of erythema multiforme in children.

G. Shklar, P. McCarthy, 1966, Oral surgery, oral medicine, and oral pathology.

The evolution of the evidence-based review: evaluating the science enhances the art of medicine--statement of the Steering Committee for Evidence-Based Reviews of the American Society for Blood and Marrow Transplantation.

J. Wingard, Y. Nieto, P. McCarthy, 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Sibling versus unrelated donor allogeneic hematopoietic cell transplantation for chronic myelogenous leukemia: refined HLA matching reveals more graft-versus-host disease but not less relapse.

A. Gratwohl, J. Szer, M. Horowitz, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Race and socioeconomic status influence outcomes of unrelated donor hematopoietic cell transplantation.

J. Klein, D. Friedman, K. Ballen, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Reducing the risk for transplantation-related mortality after allogeneic hematopoietic cell transplantation: how much progress has been made?

M. Pasquini, K. Ballen, H. Khoury, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Recombinant human interleukin-1 receptor antagonist in the treatment of steroid-resistant graft-versus-host disease

E. Guinan, K. Ballen, B. Bierer, 1994 .

Reduced-Intensity Conditioning with Fludarabine, Melphalan, and Total Body Irradiation for Allogeneic Hematopoietic Cell Transplantation: The Effect of Increasing Melphalan Dose on Underlying Disease and Toxicity.

G. Wilding, A. Hutson, P. Wallace, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Increasing use of allogeneic hematopoietic cell transplantation in patients aged 70 years and older in the United States.

W. Wood, M. Sorror, F. Baron, 2017, Blood.

Identification and Utilization of Donor and Recipient Genetic Variants to Predict Survival After HCT: Are We Ready for Primetime?

Lara E Sucheston-Campbell, Lara E. Sucheston-Campbell, Qianqian Zhu, 2015, Current Hematologic Malignancy Reports.

Muromonab-CD3 (Orthoclone OKT3®), methylprednisolone and cyclosporine for acute graft-versus-host disease prophylaxis in allogeneic bone marrow transplantation

P. Wallace, P. McCarthy, B. Bambach, 2006, Bone Marrow Transplantation.

Corticosteroids versus other single drugs or drug combinations for treatment of acute and chronic graft versus host disease (GvHD) after allogenic stem cell transplantation

H. Salmasian, M. Rohanizadegan, P. McCarthy, 2006 .

Prospective Validation of the Predictive Power of the Hematopoietic Cell Transplantation Comorbidity Index: A Center for International Blood and Marrow Transplant Research Study.

M. Sorror, M. Pasquini, M. Horowitz, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Long-term follow-up of BMT CTN 0702 (STaMINA) of postautologous hematopoietic cell transplantation (autoHCT) strategies in the upfront treatment of multiple myeloma (MM).

N. Geller, A. Krishnan, P. Hari, 2020 .

Autologous Transplantation, Consolidation, and Maintenance Therapy in Multiple Myeloma: Results of the BMT CTN 0702 Trial.

N. Geller, A. Krishnan, R. Vij, 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Updated analysis of CALGB 100104 (Alliance): a randomised phase III study evaluating lenalidomide vs placebo maintenance after single autologous stem cell transplant for multiple myeloma

Scott E. Smith, Sin-Ho Jung, K. Owzar, 2017, The Lancet. Haematology.

Thrombotic Microangiopathy after Allogeneic Blood and Marrow Transplantation Is Associated with Dose-Intensive Myeloablative Conditioning Regimens, Unrelated Donor, and Methylprednisolone T-Cell Depletion

M. Czuczman, P. McCarthy, B. Bambach, 2004, Transplantation.

Pre-Transplant C-Reactive Protein (CRP), Ferritin and Albumin As Biomarkers to Predict Transplant Related Mortality (TRM) after Allogeneic Hematopoietic Cell Transplant (HCT)

M. Pasquini, U. Popat, Xiaochun Zhu, 2014 .

Autologous reconstitution leading to sustained JAK2-V617F negativity post allogeneic hematopoietic stem cell transplant in JAK2-V617F positive myelofibrosis

G. Deeb, P. McCarthy, T. Hahn, 2015, Bone Marrow Transplantation.

Impact of conditioning regimen on peripheral blood hematopoietic cell transplant

Anurag K. Singh, P. Wallace, P. McCarthy, 2019, World journal of clinical oncology.

Developments in continuous therapy and maintenance treatment approaches for patients with newly diagnosed multiple myeloma

H. Goldschmidt, M. Dimopoulos, A. Jakubowiak, 2020, Blood Cancer Journal.

P. Bierman, E. Montserrat, K. Ballen, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Comparison of Non-myeloablative Conditioning Regimens for Lymphoproliferative Disorders

M. Pasquini, P. McCarthy, B. Logan, 2014, Bone Marrow Transplantation.

Autologous stem cell transplantation in multiple myeloma patients <60 vs ⩾60 years of age

S. Jagannath, R. Kyle, J. Wingard, 2003, Bone Marrow Transplantation.

Effect of acute and chronic graft-versus-host disease on relapse and survival after reduced-intensity conditioning allogeneic transplantation for myeloma

S. Lonial, P. Hari, A. Dispenzieri, 2011, Bone Marrow Transplantation.

Establishment of Definitions and Review Process for Consistent Adjudication of Cause-specific Mortality after Allogeneic Unrelated-donor Hematopoietic Cell Transplantation.

Lara E Sucheston-Campbell, Lara E. Sucheston-Campbell, D. Tritchler, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Metabolic syndrome and cardiovascular disease following hematopoietic cell transplantation: screening and preventive practice recommendations from CIBMTR and EBMT

M. Norkin, W. Wood, J. Snowden, 2016, Bone Marrow Transplantation.

Cutaneous sarcoidosis in a patient with philadelphia‐positive chronic myelogenous leukemia treated with interferon‐α

P. McCarthy, G. Carrum, S. Bruce, 1998, American journal of hematology.

High-dose versus standard chemotherapy in metastatic breast cancer: comparison of Cancer and Leukemia Group B trials with data from the Autologous Blood and Marrow Transplant Registry.

D. Berry, J. Klein, H. Parnes, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A TLR5 Agonist Enhances CD8+ T Cell-Mediated Graft-versus-Tumor Effect without Exacerbating Graft-versus-Host Disease

A. Gudkov, Jingxin Qiu, L. Burdelya, 2012, The Journal of Immunology.

Granzyme B–Mediated Damage of CD8+ T Cells Impairs Graft-versus-Tumor Effect

Jingxin Qiu, P. McCarthy, Xuefang Cao, 2013, The Journal of Immunology.

Granzyme B Contributes to the Optimal Graft-Versus-Tumor Effect Mediated by Conventional CD4+ T Cells

Jingxin Qiu, P. McCarthy, Xuefang Cao, 2016, Journal of immunology research and therapy.

Financial Impact of Allogeneic Hematopoietic Cell Transplantation on Patients and Families over 2-years: Results from a Multicenter Pilot Study

Stephanie J. Lee, P. McCarthy, T. Hahn, 2016, Bone Marrow Transplantation.

Host-Derived Serine Protease Inhibitor 6 Provides Granzyme B-Independent Protection of Intestinal Epithelial Cells in Murine Graft-versus-Host Disease.

E. Repasky, Jingxin Qiu, P. McCarthy, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Serine protease inhibitor 6 protects alloreactive T cells from Granzyme B-mediated mitochondrial damage without affecting graft-versus-tumor effect

Kelvin P Lee, Jingxin Qiu, P. McCarthy, 2018, Oncoimmunology.

This information is current as Signaling-Adrenergic Receptor 2 β Disease through Suppressing Murine Graft-versus-Host Induced Stress Is − Housing Temperature

J. Farrar, E. Repasky, Jingxin Qiu, 2015 .

Exome chip analyses identify genes affecting mortality after HLA-matched unrelated-donor blood and marrow transplantation.

Lara E Sucheston-Campbell, Lara E. Sucheston-Campbell, C. Haiman, 2018, Blood.

Novel genetic variants associated with mortality after unrelated donor allogeneic hematopoietic cell transplantation

Lara E Sucheston-Campbell, Abbas A. Rizvi, Lara E. Sucheston-Campbell, 2021, EClinicalMedicine.

Autologous hematopoietic stem cell transplantation and maintenance therapy for multiple myeloma

K. Owzar, P. McCarthy, T. Hahn, 2013 .

Part I: the role of maintenance therapy in patients with multiple myeloma undergoing autologous hematopoietic stem cell transplantation.

P. McCarthy, 2013, Journal of the National Comprehensive Cancer Network : JNCCN.

Allogeneic bone marrow transplantation for low-grade lymphoma.

J. Armitage, J. Vose, J. Raemaekers, 1998, Blood.

Molecular Epidemiology and Risk Factors for Colonization by Vancomycin-Resistant Enterococcus in Patients with Hematologic Malignancies

P. McCarthy, A. Lesse, G. Samonis, 2011, Infection Control & Hospital Epidemiology.

Effect of obesity on outcomes after autologous hematopoietic stem cell transplantation for multiple myeloma.

D. Heitjan, P. Hari, R. Kyle, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Fludarabine and cyclophosphamide provides a nonmyeloablative alternative conditioning regimen with low transplant-related mortality and control of high risk disease

P. McCarthy, T. Hahn, P. Paplham, 2014, Leukemia research reports.

IS THE INTERNATIONAL STAGING SYSTEM SUPERIOR TO THE DURIE SALMON STAGING SYSTEM? A COMPARISON IN MULTIPLE MYELOMA PATIENTS UNDERGOING AUTOLOGOUS TRANSPLANT

P. Hari, R. Kyle, D. Reece, 2009, Leukemia.

Seeing what's out of sight: wireless capsule endoscopy's unique ability to visualize and accurately assess the severity of gastrointestinal graft-versus-host-disease.

P. McCarthy, T. Hahn, M. Battiwalla, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Bone marrow transplants from HLA-identical siblings in advanced Hodgkin's disease.

J. Armitage, J. Vose, J. Klein, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

MYELOABLATIVE ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN PATIENTS WHO RELAPSE AFTER AUTOLOGOUS STEM CELL TRANSPLANTATION FOR LYMPHOMA: A REPORT OF THE INTERNATIONAL BONE MARROW TRANSPLANT REGISTRY Running head: Allogeneic transplants after autologous failure For Submission to BLOOD, Trans

J. Vose, M. Horowitz, R. Gale, 2004 .

The outcome of full-intensity and reduced-intensity conditioning matched sibling or unrelated donor transplantation in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia in first and second complete remission.

J. Szer, B. George, M. Tallman, 2010, Blood.

Studies of MIF and the role of macrophage associated esterases in the response of the macrophage to MIF.

P. McCarthy, H. Remold, A. Mednis, 1979, Advances in experimental medicine and biology.

Optical Coherence Tomography for Quantifying Human Cutaneous Chronic Graft-versus-Host Disease.

Chulhong Kim, P. McCarthy, T. Hahn, 2021, Transplantation and cellular therapy.

A prognostic model for prolonged event-free survival after autologous or allogeneic blood or marrow transplantation for relapsed and refractory Hodgkin's disease

M. Czuczman, K. Moysich, P. McCarthy, 2005, Bone Marrow Transplantation.

Autologous T cell therapy for MAGE-A4+ solid cancers in HLA-A*02+ patients: a phase 1 trial

F. Bushman, Melissa L. Johnson, B. V. Van Tine, 2023, Nature Medicine.

Fatal hyperacute graft-versus-host disease following denileukin diftitox treatment for recurrent t cell lymphoma after allogeneic stem cell transplantation.

R. Cheney, G. Deeb, P. McCarthy, 2009, Biology of Blood and Marrow Transplantation.

Long-term survival after transplantation of unrelated donor peripheral blood or bone marrow hematopoietic cells for hematologic malignancy.

R. Vij, P. McCarthy, B. Logan, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Spatiotemporal assessment of immunogenomic heterogeneity in multiple myeloma

Q. Hu, Song Liu, N. Munshi, 2020, Blood advances.

Methods to prevent and treat relapse after hematopoietic stem cell transplantation with tyrosine kinase inhibitors, immunomodulating drugs, deacetylase inhibitors, and hypomethylating agents

N. Kröger, M. Bishop, Yi-Bin Chen, 2018, Bone Marrow Transplantation.

AMD3100 Combined with Standard Doses of G-Csf Leads to Rapid, Consistent Mobilization of Hematopoietic Progenitor Cells in Patients with Non-Hodgkin’s Lymphoma (NHL) and Multiple Myeloma.

G. Tricot, M. Territo, P. McCarthy, 2004 .

Back to the future! The evolving role of maintenance therapy after hematopoietic stem cell transplantation.

C. Hourigan, P. McCarthy, M. de Lima, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Reprint of: Back to the future! The evolving role of maintenance therapy after hematopoietic stem cell transplantation.

C. Hourigan, P. McCarthy, M. de Lima, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Low-level Cytomegalovirus Antigenemia Promotes Protective Cytomegalovirus Antigen Specific T-Cells after Allogeneic Hematopoietic Cell Transplantation.

P. Wallace, P. McCarthy, J. Tario, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Second autologous stem cell transplantation for relapsed lymphoma after a prior autologous transplant.

J. Vose, Sonali M. Smith, P. Hari, 2008, Biology of Blood and Marrow Transplantation.

β2 Adrenergic receptor-mediated signaling regulates the immunosuppressive potential of myeloid-derived suppressor cells.

B. Hylander, E. Repasky, S. Abrams, 2019, The Journal of clinical investigation.

Autologous or allogeneic stem cell transplantation in patients with Waldenstrom's macroglobulinemia.

H. Goldschmidt, P. Hari, D. Reece, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Galectin-3 expression in donor T cells reduces GvHD severity and lethality after allogeneic hematopoietic cell transplantation

K. Odunsi, E. Repasky, Jingxin Qiu, 2023, Cell reports.

Lenalidomide in combination or alone as maintenance therapy following autologous stem cell transplant in patients with multiple myeloma: a review of options for and against

P. Richardson, S. Holstein, P. McCarthy, 2017, Expert opinion on pharmacotherapy.

Improved survival with salvage autologous stem-cell transplantation in myeloma.

S. Holstein, P. McCarthy, 2016, The Lancet Haematology.

Consolidation and maintenance therapy for multiple myeloma after autologous transplantation: where do we stand?

P. Richardson, M. Mohty, P. McCarthy, 2015, Bone Marrow Transplantation.

Management of relapsed multiple myeloma after autologous stem cell transplant.

J. Laubach, P. Richardson, S. Holstein, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

The evolving field of post-transplant therapy in multiple myeloma

S. Holstein, P. McCarthy, 2014 .

Second transplant as a standard for multiple myeloma.

P. McCarthy, 2014, The Lancet. Oncology.

New developments in post-transplant maintenance treatment of multiple myeloma.

P. McCarthy, Hong Liu, 2013, Seminars in oncology.

Anatomy of a successful practice-changing study: a Blood and Marrow Transplantation Clinical Trials Network-National Cancer Institute Cooperative Group collaboration.

P. Richardson, S. Rajkumar, M. Pasquini, 2013, Biology of Blood and Marrow Transplantation.

Childhood leukaemia in Belarus, Russia, and Ukraine following the Chernobyl power station accident: results from an international collaborative population-based case-control study.

M. Mahoney, K. Moysich, K. Kopecky, 2006, International journal of epidemiology.

J. Sierra, M. Tallman, R. Gale, 2008, Blood.

Dennis Confer, Theresa Hahn, P. McCarthy, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Allogeneic hematopoietic cell transplantation for advanced polycythemia vera and essential thrombocythemia.

H. Deeg, D. Porter, J. Cortes, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Serological Response to Vaccination after Autologous Transplantation for Multiple Myeloma Is Associated with Improved Progression-Free and Overall Survival.

A. Merz, M. Merz, P. McCarthy, 2021, Transplantation and cellular therapy.

Ascertainment of Unmet Needs and Participation in Health Maintenance and Screening of Adult Hematopoietic Cell Transplantation Survivors Followed in a Formal Survivorship Program.

P. McCarthy, T. Hahn, M. Ross, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Metabolic syndrome and cardiovascular disease following hematopoietic cell transplantation: screening and preventive practice recommendations from CIBMTR and EBMT

Hamadani, M. Norkin, W. Wood, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

The prognostic value of serum C-reactive protein, ferritin, and albumin prior to allogeneic transplantation for acute myeloid leukemia and myelodysplastic syndromes

M. Pasquini, A. Wickrema, U. Popat, 2016, Haematologica.

The role of cytotoxic therapy with hematopoietic stem cell transplantation in the treatment of pediatric acute lymphoblastic leukemia: update of the 2005 evidence-based review. ASBMT Position Statement.

P. Gaynon, P. McCarthy, M. Pulsipher, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

The role of cytotoxic therapy with hematopoietic stem cell transplantation in the treatment of adult acute lymphoblastic leukemia: update of the 2006 evidence-based review.

R. Larson, P. McCarthy, T. Ratko, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Managing cardiac amyloidosis: Auto or allotransplant?

P. McCarthy, T. Hahn, M. Ross, 2011, American journal of hematology.

Immune signatures associated with improved progression-free and overall survival for myeloma patients treated with AHSCT.

P. Wallace, B. Paiva, S. Holstein, 2017, Blood advances.

Methodological considerations for the high sensitivity detection of multiple myeloma measurable residual disease

P. Wallace, P. McCarthy, J. Tario, 2019, Cytometry. Part B, Clinical cytometry.

Where are we going with autologous transplantation for multiple myeloma?

P. McCarthy, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Influence of age and histology on outcome in adult non-Hodgkin lymphoma patients undergoing autologous hematopoietic cell transplantation (HCT): a report from the Center For International Blood & Marrow Transplant Research (CIBMTR).

Alan M. Miller, J. Armitage, J. Vose, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Early versus late preemptive allogeneic hematopoietic cell transplantation for relapsed or refractory acute myeloid leukemia.

P. Wallace, G. Deeb, S. Sait, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

lymphoblastic leukemia in first complete remission Unrelated donor transplants in adults with Philadelphia-negative acute

J. Sierra, R. Gale, M. Bishop, 2011 .

Allogeneic transplantation for low-grade lymphoma: long-term follow-up.

K. van Besien, P. McCarthy, K. Besien, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Accelerated bone mineral density loss occurs with similar incidence and severity, but with different risk factors, after autologous versus allogeneic hematopoietic cell transplantation.

P. McCarthy, T. Hahn, M. Battiwalla, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Obesity does not preclude safe and effective myeloablative hematopoietic cell transplantation (HCT) for acute myelogenous leukemia (AML) in adults.

M. Pasquini, K. Ballen, J. Liesveld, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Pretransplantation consolidation chemotherapy decreases leukemia relapse after autologous blood and bone marrow transplants for acute myelogenous leukemia in first remission.

J. Sierra, A. Zander, M. Horowitz, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Sibling versus Unrelated Donor Allogeneic Hematopoietic Cell Transplantation for CML: Refined HLA-matching shows more GVHD but not less relapse Blood Marrow

J. Szer, M. Horowitz, Stephanie J. Lee, 2010 .

Survival Analysis from the CALGB Study of Lenalidomide Maintenance Therapy in Newly Diagnosed Multiple Myeloma Post-Autologous Stem Cell Transplantation Adjusted for Crossover (Alliance 100104)

P. Richardson, V. Suman, S. Holstein, 2018, Blood.

Overall Survival (OS) and Progression-Free Survival (PFS) Adjusted for Treatment Crossover in the CALGB/ECOG 100104 (Alliance) Study of Lenalidomide (LEN) Versus Placebo (PBO) Maintenance After Stem Cell Transplant (SCT) for Patients With Newly Diagnosed Multiple Myeloma

Sin-Ho Jung, P. Richardson, S. Holstein, 2017 .

Histopathologic verification of acute leukemia (AL) in a cohort of 463 post-Chernobyl patients from Belarus, Russia and Ukraine.

K. Kopecky, P. McCarthy, O. Paltiel, 2004, Leukemia research.

Replication of associations between genetic polymorphisms and chronic graft-versus-host disease.

Lara E Sucheston-Campbell, Lara E. Sucheston-Campbell, L. Zhao, 2016, Blood.

Maintenance therapy for multiple myeloma.

P. McCarthy, A. Palumbo, 2014, Hematology/oncology clinics of North America.

Dapsone-induced methemoglobinemia after hematopoietic stem cell transplantation.

P. McCarthy, T. Hahn, M. Battiwalla, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

The role of cytotoxic therapy with hematopoietic stem cell transplantation in the treatment of diffuse large cell B-cell non-Hodgkin's lymphoma.

J. Vose, M. Czuczman, R. Fisher, 2003, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Autologous bone marrow transplantation in primary breast cancer : the American experience

J. Fay, L. Akard, C. Cirrincione, 1995 .

The effect of smoking on allogeneic transplant outcomes.

K. Ballen, O. Ringdén, P. McCarthy, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Impact of Autologous Hematopoietic Cell Transplant (HCT) Followed By Dendritic Cell/Myeloma Fusion Vaccine with Lenalidomide Maintenance in Increasing Multiple Myeloma (MM) Immunity (BMT CTN 1401)

N. Geller, N. Munshi, M. Pasquini, 2021, Blood.

ZUMA-19: A Phase 1/2 Multicenter Study of Lenzilumab Use With Axicabtagene Ciloleucel (Axi-Cel) in Patients (Pts) With Relapsed or Refractory Large B Cell Lymphoma (R/R LBCL)

P. McCarthy, S. Neelapu, O. Oluwole, 2020 .

Rituximab in combination with CHOP or fludarabine in low-grade lymphoma.

M. Czuczman, P. McCarthy, D. Klippenstein, 2002, Seminars in oncology.

Cutaneous lesions resulting from sinuses of dental origin.

P. McCarthy, 1981, The Journal of Dermatologic Surgery and Oncology.

Pulmonary hypertension and thalidomide therapy in multiple myeloma. Authors' reply

Y. Ikeda, M. Shimoda, P. McCarthy, 2005 .

Diseases of the oral mucosa : diagnosis, management, therapy

G. Shklar, P. McCarthy, 1964 .

25 years after Chernobyl: lessons for Japan?

Per Hall, Philip McCarthy, P. Hall, 2011, The Lancet. Oncology.

Employment, Insurance, and Financial Experiences of Patients with Chronic Graft-versus-Host Disease in North America.

G. Abel, W. Wood, J. Pidala, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Mass-Fix better predicts for PFS and OS than standard methods among multiple myeloma patients participating on the STAMINA trial (BMT CTN 0702 /07LT)

N. Geller, A. Krishnan, P. Hari, 2022, Blood Cancer Journal.

Host-derived Spi6 provides granzyme B-independent protection of intestinal epithelial cells in murine GVHD

Jingxin Qiu, P. McCarthy, S. Khalili, 2018 .

Long-term stability of a patient-convenient 1 mg/ml suspension of tacrolimus for accurate maintenance of stable therapeutic levels

P. McCarthy, T. Hahn, M. Battiwalla, 2006, Bone Marrow Transplantation.

Second primary malignancies (SPM) in newly diagnosed myeloma (MM) patients treated with lenalidomide (Len): Meta-analysis of 6,383 individual patient data (IPD).

B. Barlogie, M. Dimopoulos, P. Sonneveld, 2013 .

Oral manifestations of benign mucous membrane pemphigus (mucous membrane pemphigoid); review of the literature and report of fifteen cases.

G. Shklar, P. McCarthy, 1959, Oral surgery, oral medicine, and oral pathology.

Commentary: A perspective on clinical disorders of radiation accident victims

P. McCarthy, 1997, Stem Cells.

Replicated Risk Index of Patient Functional Status Prior to Allogeneic Hematopoietic Cell Transplant Predicts Healthcare Utilization and Survival.

S. Rehman, P. McCarthy, T. Hahn, 2021, Transplantation and cellular therapy.

Prospective Validation of the Predictive Power of the Hematopoietic Cell Transplantation Comorbidity Index (HCT-CI) for HCT Outcomes At US Transplant Centers: A Center for International Blood and Marrow Transplant Research (CIBMTR) Study

M. Sorror, B. Storer, M. Pasquini, 2012 .

b2 adrenergic receptor–mediated signaling regulates the immunosuppressive potential of myeloid-derived suppressor cells

B. Hylander, E. Repasky, S. Abrams, 2019 .

Infants with fever.

P. McCarthy, 1993, The New England journal of medicine.

Phase III Intergroup Study of Lenalidomide (CC-5013) Versus Placebo Maintenance Therapy Following Single Autologous Stem Cell Transplant for Multiple Myeloma (CALGB 100104): Initial Report of Patient Accrual and Adverse Events.

K. Owzar, C. Hofmeister, P. Richardson, 2009 .

Association of Baseline and Postinfusion Biomarkers with Safety and Efficacy Endpoints in Patients Treated with Orvacabtagene Autoleucel (orva-cel; JCARH125) in the Phase 1/2 Evolve Study (NCT03430011)

P. McCarthy, T. Devries, S. Mailankody, 2020 .

Synchronous presentation of monoclonal gammopathy and Fabry nephropathy; diagnostic renal biopsy obviates initiation of myeloma therapy

S. Holstein, P. McCarthy, J. Czyzyk, 2015, Annals of Hematology.

TNF-alpha response of human monocyte-derived macrophages to Mycobacterium avium, serovar 4, is of brief duration and protein kinase C dependent.

P. McCarthy, H. Gan, H. Remold, 1993, Journal of immunology.

Improved Survival with Intravenous Busulfan (IV BU) Compared to Total Body Irradiation (TBI)-Based Myeloablative Conditioning Regimens: A CIBMTR Prospective Study

M. Pasquini, Xiaochun Zhu, P. McCarthy, 2013 .

Identification of neurotoxicity after chimeric antigen receptor (CAR) T-cell infusion without deterioration in the immune effector cell encephalopathy (ICE) score.

P. McCarthy, T. Hahn, M. Ross, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Reduced-intensity conditioning allogeneic hematopoietic cell transplantation for patients with hematologic malignancies who relapse following autologous transplantation: a multi-institutional prospective study from the Cancer and Leukemia Group B (CALGB trial 100002).

K. Owzar, S. Farag, T. Shea, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Significant Improvement In Overall Survival In Patients Who Underwent Autologous Hematopoietic Cell Transplant In the US or Canada Between 1994 and 2005

J. Klein, P. McCarthy, S. Parsons, 2010 .

The Effects of Rituximab Added to Front-Line or Salvage Chemotherapy in Diffuse Large B-Cell Lymphoma (DLBCL) Undergoing High-Dose Chemotherapy (HDC) and Autologous Stem Cell Transplant (ASCT).

M. Czuczman, A. Chanan-Khan, F. Hernandez-Ilizaliturri, 2008 .

Autologous transplantation for diffuse aggressive non-Hodgkin lymphoma in first relapse or second remission.

J. Armitage, J. Vose, M. Horowitz, 2004, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Autologous transplantation for diffuse aggressive non-Hodgkin's lymphoma in patients never achieving remission: a report from the Autologous Blood and Marrow Transplant Registry.

J. Armitage, J. Vose, E. Montserrat, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Retrospective multivariate analysis of hepatic veno-occlusive disease after blood or marrow transplantation: possible beneficial use of low molecular weight heparin

M. Czuczman, P. McCarthy, B. Bambach, 2001, Bone Marrow Transplantation.

Developments in continuous therapy and maintenance treatment approaches for patients with newly diagnosed multiple myeloma

H. Goldschmidt, M. Dimopoulos, A. Jakubowiak, 2020, Blood Cancer Journal.

Short term storage of mobilized peripheral blood stem cells in a closed system changes the microenvironment and may affect the quantity of CD34+ and CD34+CD38-CD45RA-CD90+ cells: Effect of airtight storage on HSCs.

P. McCarthy, O. Maguire, H. Minderman, 2022, Transplantation and cellular therapy.

Harvesting Hematopoietic Progenitors : “ Please Release Me , Let Me Go ”

K. Ballen, P. McCarthy, P. Mcsweeney, 2022 .

Thalidomide (T) in Combination with Fludarabine (F) as Initial Therapy for Patients (pts) with Treatment Naïve Chronic Lymphocytic Leukemia (CLL): Results of a Phase I Trial.

M. Czuczman, K. Takeshita, A. Chanan-Khan, 2004 .

“Stimulate the phagocytes!” Fascin-ating! Are DCs actin' up?

P. McCarthy, 2007 .

The role of cytotoxic therapy with hematopoietic stem cell transplantation in the treatment of follicular lymphoma: an evidence-based review.

L. Gordon, J. Leonard, P. Mclaughlin, 2010, Biology of Blood and Marrow Transplantation.

Purification of guinea pig pH 3 migration inhibitory factor.

P. McCarthy, H. Remold, A. Mednis, 1981, Proceedings of the National Academy of Sciences of the United States of America.

Quantifying MHC dextramer-induced NFAT activation in antigen-specific T cells as a functional response parameter.

P. Wallace, P. McCarthy, O. Maguire, 2017, Methods.